Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Notified -
Globe Newswire17-02-2026, 18:00
At the Yacht Club de Monaco the Navicap Challenge - Trophée Elena Sivoldaeva 25-11-2024, 22:26